Miriam Tendler
Rio De Janeiro, RJ 22611100, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa.
Journal: Vaccines
Published: January 15, 2025
Developing anti-helminth vaccines for people and cattle: (For)seeing the one health approach in action.
Journal: One health (Amsterdam, Netherlands)
Published: May 30, 2023
Correction: Tendler, M., et al. Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine. Trop. Med. Infect. Dis. 2018, 3, 121.
Journal: Tropical medicine and infectious disease
Published: January 16, 2019
Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine.
Journal: Tropical medicine and infectious disease
Published: October 15, 2018
Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant.
Journal: Frontiers in immunology
Published: February 11, 2015
The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
Journal: Acta tropica
Published: August 07, 2007
Showing 1-9 of 9
Last Updated: 09/26/2026